M. Cifaldi

8.9k total citations
20 papers, 324 citations indexed

About

M. Cifaldi is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, M. Cifaldi has authored 20 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in M. Cifaldi's work include Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). M. Cifaldi is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). M. Cifaldi collaborates with scholars based in United States, United Kingdom and Germany. M. Cifaldi's co-authors include Philip J. Mease, Eric H. Sasso, J Medich, Renee Perdok, Dafna D. Gladman, Michael T. Halpern, T.K. Kvien, Gene Colice, Howard G. Birnbaum and Melissa Morley and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Lara D. Veeken.

In The Last Decade

M. Cifaldi

20 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cifaldi United States 8 181 105 92 53 41 20 324
M. Greenwood United Kingdom 6 141 0.8× 53 0.5× 57 0.6× 18 0.3× 20 0.5× 9 305
René Østgård Denmark 9 144 0.8× 70 0.7× 103 1.1× 13 0.2× 12 0.3× 24 289
H.‐J. Lakomek Germany 12 327 1.8× 97 0.9× 119 1.3× 6 0.1× 62 1.5× 54 591
C Popescu Romania 9 129 0.7× 50 0.5× 70 0.8× 14 0.3× 56 1.4× 48 257
Penélope Esther Palominos Brazil 12 208 1.1× 108 1.0× 137 1.5× 13 0.2× 32 0.8× 34 321
Emilce E. Schneeberger Argentina 11 294 1.6× 97 0.9× 119 1.3× 11 0.2× 22 0.5× 47 379
Pirjo Tynjälä Finland 9 249 1.4× 496 4.7× 73 0.8× 12 0.2× 18 0.4× 15 639
Heidi Lausten Munk Denmark 9 113 0.6× 50 0.5× 85 0.9× 10 0.2× 36 0.9× 21 307
Marie Couret France 8 144 0.8× 68 0.6× 42 0.5× 8 0.2× 33 0.8× 13 266
Inderpal Randhawa United States 10 21 0.1× 18 0.2× 26 0.3× 87 1.6× 33 0.8× 38 287

Countries citing papers authored by M. Cifaldi

Since Specialization
Citations

This map shows the geographic impact of M. Cifaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cifaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cifaldi more than expected).

Fields of papers citing papers by M. Cifaldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cifaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cifaldi. The network helps show where M. Cifaldi may publish in the future.

Co-authorship network of co-authors of M. Cifaldi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cifaldi. A scholar is included among the top collaborators of M. Cifaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cifaldi. M. Cifaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aiello, L., M. Lorenzini, E. Cesarini, et al.. (2024). Thermal defocus-free Hartmann Wavefront Sensors for monitoring aberrations in Advanced Virgo. Classical and Quantum Gravity. 41(12). 125001–125001. 1 indexed citations
2.
Stephens, Sue, Marc Botteman, M. Cifaldi, & Ben A. van Hout. (2015). Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease. BMJ Open. 5(6). e006560–e006560. 10 indexed citations
3.
Ganguli, Arijit, et al.. (2014). The economic burden of osteoarthritis in Americans: analysis from a privately insured population. Osteoarthritis and Cartilage. 22. S210–S210. 6 indexed citations
4.
Pappas, Dimitrios A., Hsiaochi Chang, M. Cifaldi, et al.. (2014). AB0379 Laboratory Safety of Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 931–931. 2 indexed citations
5.
Revicki, Dennis A., et al.. (2013). AB0266 Responsiveness and minimal important difference of the rheumatoid arthritis-work instability scale (ra-wis). Annals of the Rheumatic Diseases. 72. A867–A867. 3 indexed citations
6.
Wang, X., et al.. (2012). PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany. Value in Health. 15(7). A446–A446. 1 indexed citations
7.
Sieper, Joachim, et al.. (2012). FRI0286 Burden of the disease in axial spondyloarthritis. Annals of the Rheumatic Diseases. 71. 410–411. 2 indexed citations
8.
9.
Landewé, R., Edward Keystone, Smolen Js, et al.. (2011). DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH EARLY RA TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT METHOTREXATE ALONE: CASE FOR ANTI-TNF CARTILAGE PROTECTION. Lara D. Veeken. 50. 113–113. 2 indexed citations
10.
11.
Kimel, Miriam, Dennis A. Revicki, Sumati Rao, et al.. (2011). Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis.. PubMed. 29(4). 624–32. 7 indexed citations
12.
Halpern, Michael T., M. Cifaldi, & T.K. Kvien. (2008). Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group. Annals of the Rheumatic Diseases. 68(6). 930–937. 38 indexed citations
13.
14.
Gladman, Dafna D., Philip J. Mease, M. Cifaldi, et al.. (2006). Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Annals of the Rheumatic Diseases. 66(2). 163–168. 105 indexed citations
15.
Wu, E.Q., et al.. (2006). Development of a COPD severity score. Current Medical Research and Opinion. 22(9). 1679–1687. 25 indexed citations
16.
17.
18.
Birnbaum, Howard G., et al.. (2001). Economic Burden of Pneumonia in an Employed Population. Archives of Internal Medicine. 161(22). 2725–2725. 34 indexed citations
19.
Cifaldi, M., et al.. (1999). Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.. PubMed. 5(4 Suppl). S225–34. 11 indexed citations
20.
Cifaldi, M., et al.. (1999). Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population.. PubMed. 5(4). 485–96. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Greenwood Breakdown of academic impact, for papers by René Østgård Breakdown of academic impact, for papers by H.‐J. Lakomek Breakdown of academic impact, for papers by C Popescu Breakdown of academic impact, for papers by Penélope Esther Palominos Breakdown of academic impact, for papers by Emilce E. Schneeberger Breakdown of academic impact, for papers by Pirjo Tynjälä Breakdown of academic impact, for papers by Heidi Lausten Munk Breakdown of academic impact, for papers by Marie Couret Breakdown of academic impact, for papers by Inderpal Randhawa
Rankless by CCL
2026